NATR

Natures Sunshine Products

Fundamental data last updated:April 13, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Consumer Defensive

industry

Packaged Foods

Exchange

Nasdaq

County of HQ

United States

Next Earnings Date

05/05/26

Business Summary

Nature’s Sunshine Products operates in the nutritional supplements and packaged health products space, generating revenue through branded consumer health offerings sold via a mix of direct selling and retail channels. The business model converts raw ingredient sourcing and formulation expertise into branded, higher-margin finished goods, allowing it to capture value through product differentiation rather than commodity pricing. Cash flow is driven by repeat purchases in health-oriented categories, which tend to exhibit defensive demand characteristics. Its moat is rooted in brand credibility, established distribution relationships, and operational scale within its niche of the broader packaged foods and supplements market.

 


Analyze NATR on TradingView

VALUATION

P/E

25.4

Market Cap ($M USD)

$471

Forward P/E

21.9

PEG

-

PRICE TO SALES

1

PRICE TO BOOK

2.9

EV / EBITDA

9.1

5-Year Average P/E

Free Cash Flow Yield

DCF Value

Graham Number

Price to FCF

EV to FCF

Earnings Yield

FCF Yield

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

$1.08

Next Year EPS Growth Estimate

$1.23

Next Year Revenue Growth Estimate

3.70%

Return on Equity (ROE)

12.10%

FREE CASH FLOW

Operating Margin

5.20%

Debt-to-Equity

0.1

Piotroski F-Score

7

Altman Z-Score

5.9

Return on Invested Capital (ROIC)

10.90%

Current Ratio

2.3

Quick Ratio

Net Debt to EBITDA

Interest Coverage

Gross Profit margin

FCF PER SHARE

REVENUE PER SHARE

Analyze NATR on TradingView

Gainseekers Quantitative Analysis

Summary

At 25.4x earnings and 21.9x forward earnings, the market is not pricing NATR as a distressed name, yet it’s far from expensive given a 5.9 Altman Z-Score and a 7 Piotroski F-Score signaling strong balance sheet integrity and operational stability. A 1x Price/Sales and 2.9x Price/Book suggest the stock is trading at a reasonable valuation relative to assets and revenue base, particularly in a defensive sector. The combination of a 10.90% ROIC and 12.10% operating margin indicates a business that is generating real economic profit, even if Return on Equity at 3.70% remains muted. This is not a deep value cigar butt, but it may represent a modestly undervalued, financially secure compounder within Consumer Defensive.

AI Exposure / Tech Reliance

As a Packaged Foods company in Consumer Defensive, NATR’s AI exposure is indirect but meaningful through supply chain optimization, demand forecasting, and digital direct-to-consumer channels. The industry’s resilience to economic cycles provides stability, while tech adoption can enhance margin efficiency rather than drive top-line disruption. This is a steady operator that benefits from operational AI efficiencies rather than being threatened by them.

The Bull Case

A GARP investor would be drawn to the 10.90% ROIC paired with a 12.10% operating margin, indicating disciplined capital allocation and solid operating execution in a traditionally low-growth sector. The Piotroski F-Score of 7 reinforces improving or stable financial conditions, while the 5.9 Altman Z-Score signals negligible bankruptcy risk. With Price/Sales at 1 and Price/Book at 2.9, investors are not overpaying for revenue or net assets, and a Forward P/E of 21.9 suggests reasonable expectations relative to earnings visibility. Add in a conservative Debt/Equity of 5.20% and a healthy 2.3 current ratio, and you have a balance sheet capable of funding growth without financial strain.

The Bear Case

The red flags are subtle but real: Return on Equity at just 3.70% is weak, suggesting that despite modest leverage, equity capital is not being aggressively compounded. The absence of a PEG ratio and Short % of Float reduces visibility into growth-adjusted valuation and market skepticism. A TTM Yield of 0.1 with no meaningful dividend commitment limits shareholder return optionality, and with a Price/Earnings of 25.4, investors are still paying a premium multiple for a business with unspecified growth acceleration. If growth underwhelms, multiple compression is a real risk.

Market Sentiment & Smart Money

Short Interest %

1.80%

Analyst Consensus

1

Average Analyst Price Target

$33.00

Institutional Ownership %

84.60%

1-Year Beta

0.59

Insider Buying % (6 Mo)

2.90%%

Distance to 52-Week High

95.70%

Distance to 52-Week Low

241.50%

EARNINGS SURPRISE %

50-DAY SMA

200-DAY SMA

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.